Novel Indications for Bruton’s Tyrosine Kinase Inhibitors, beyond Hematological Malignancies
Campbell, R.; Chong, G.; Hawkes, E.A. Novel Indications for Bruton’s Tyrosine Kinase Inhibitors, beyond Hematological Malignancies. J. Clin. Med. 2018, 7, 62. https://doi.org/10.3390/jcm7040062
Campbell R, Chong G, Hawkes EA. Novel Indications for Bruton’s Tyrosine Kinase Inhibitors, beyond Hematological Malignancies. Journal of Clinical Medicine. 2018; 7(4):62. https://doi.org/10.3390/jcm7040062
Chicago/Turabian StyleCampbell, Robert, Geoffrey Chong, and Eliza A. Hawkes. 2018. "Novel Indications for Bruton’s Tyrosine Kinase Inhibitors, beyond Hematological Malignancies" Journal of Clinical Medicine 7, no. 4: 62. https://doi.org/10.3390/jcm7040062